Filana Therapeutics (FLNA) Other Operating Expenses (2018 - 2022)

Filana Therapeutics has reported Other Operating Expenses for 5 years, with the latest figure at $16.9 million in Q2 2022.

• On a quarterly basis, Other Operating Expenses rose 334.45% year-over-year to $16.9 million in Q2 2022; TTM through Mar 2023 was $16.9 million, a 54.43% decrease from a year earlier, with the FY2020 full-year figure at $346000.0, down 77.93% from the prior year.
• Other Operating Expenses was $16.9 million for Q2 2022 at Filana Therapeutics, up from $14.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $16.9 million in Q2 2022, with the low at -$1.0 million in Q3 2018.
• Average Other Operating Expenses over 5 years is $5.2 million, with a median of $2.5 million recorded in 2021.
• The sharpest annual moves came in 2019 and 2021: Other Operating Expenses soared 94.94% in 2019, then surged 2429.0% in 2021.
• Over 5 years, Other Operating Expenses stood at -$1.0 million in 2018, then soared by 171.86% to $738000.0 in 2019, then slumped by 66.67% to $246000.0 in 2020, then surged by 4104.07% to $10.3 million in 2021, then surged by 63.88% to $16.9 million in 2022.
• The last three Other Operating Expenses figures came in at $16.9 million (Q2 2022), $14.9 million (Q1 2022), and $10.3 million (Q4 2021), per Business Quant data.